Sign in

NCT05452031Recruiting

A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers

A Dyadic Approach to Improve Sleep and Well-Being Among Persons With Alzheimer's Disease and Their Caregivers

Source: ClinicalTrials.gov · Last updated 18 Jun 2026

Brief summary (registry, in English)

This is a randomized controlled trial over 5 years, using Stage II of the NIH-defined stage model for behavioral intervention development. We will evaluate the efficacy of the sleep intervention program (Care2Sleep) on sleep, health status measures, and quality of life (for dyads), and inflammation (for caregivers only). Eligible participants will be randomly assigned to in-person Care2Sleep, telehealth Care2Sleep, or to an in-person education control group. The Care2Sleep programs and the control education program will consist of five sessions. The intervention and control programs will begin after baseline assessment and randomization. Posttreatment assessments will be performed immediately after the last session and at 6-month follow-up.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
672 (estimated)
First submitted
1 Jul 2022
Start date
9 Nov 2022
Primary completion date
31 May 2027
Lead sponsor
University of California, Los Angeles
NCT number
NCT05452031

What you commit to

  • Study type: Interventional
  • Planned participants: 672
  • From 9 Nov 2022 to the primary completion date, 31 May 2027
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients will be excluded if they are bedbound or have severe medical conditions with a life expectancy of less than 6 months.

Other

  • Paid, professional caregivers will also be excluded.
  • If the eligibility criteria for either a patient or a caregiver are not met, the dyads will be excluded for this study.

Who the study is looking for

  • Have a diagnosis of Alzheimer's disease (probable or possible) or other related dementia as documented in an electronic medical record
  • Community-dwelling
  • \>1 sleep problems \>3x/week on the Neuropsychiatric Inventory Nighttime Behavior Scale, - - Aged \>60 years
  • Have no untreated sleep disorders (e.g., sleep apnea, restless legs syndrome)
  • Able to ambulate with or without assistive devices (i.e., dyads will be excluded if the care recipient is bedbound)
  • Have no severe medical conditions with a life expectancy of less than 6 months
  • Have an eligible caregiver
  • Live with an eligible patient
  • Aged \>18 years
  • Is related to the patient as a family member, a significant other, or a friend
  • Have regularly assisted patient with \>1 of 6 basic activities of daily living (ADLs; i.e., bathing, dressing, toileting, transferring, continence, feeding) or \>1 of 8 Instrumental ADL (IADLs; i.e., using the telephone, shopping, food preparation, housekeeping, laundry, transportation, taking medications, managing money) for the past 6 months
  • Pittsburgh Sleep Quality Index (PSQI) total score \>5
  • Montreal Cognitive Assessment (MoCA) ≥23
  • Can communicate in English

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University of California San Diego
Coordinator of this site? Confirm its status
La JollaUnited StatesRecruiting
University of California, Los Angeles
Coordinator of this site? Confirm its status
Los AngelesUnited StatesRecruiting
Veterans Affairs Greater Los Angeles Healthcare System
Coordinator of this site? Confirm its status
Los AngelesUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.

A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers (NCT05452031) – Frontlight Research